Brief: Bristol Myers Squibb To Showcase Next-Generation Cancer Modalities And Leadership Across Solid Tumors At Esmo 2026
Mon 12:32
BRIEF-Bristol Myers Squibb To Showcase Next-Generation Cancer Modalities And Leadership Across Solid Tumors At Esmo 2026 Oct 19 (Reuters) - Bristol-Myers Squibb Company BMY.N:
BRISTOL MYERS SQUIBB TO SHOWCASE NEXT-GENERATION CANCER MODALITIES AND LEADERSHIP ACROSS SOLID TUMORS AT ESMO 2026
Source text: ID:nBw77Yjwma
Further company coverage: BMY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bristol-Myers Squibb
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: Bristol Myers Squibb To Showcase Next-Generation Cancer Modalities And Leadership Across Solid Tumors At Esmo 2026
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Healthcare stocks rally as investors seek safety amid tech debt worries
AstraZeneca strikes $40 million AI drug discovery deal with insitro